| Primary |
| Drug Use For Unknown Indication |
43.1% |
| Sinusitis |
14.8% |
| Pneumonia |
11.1% |
| Bronchitis |
8.6% |
| Product Used For Unknown Indication |
4.6% |
| Upper Respiratory Tract Infection |
2.5% |
| Respiratory Tract Infection |
2.2% |
| Infection |
2.1% |
| Hypertension |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Lung Infection |
1.1% |
| Urinary Tract Infection |
1.0% |
| Unevaluable Event |
0.9% |
| Nasopharyngitis |
0.9% |
| Cough |
0.8% |
| Ear Infection |
0.8% |
| Acute Sinusitis |
0.7% |
| Pyrexia |
0.7% |
| Diabetes Mellitus |
0.6% |
| Bronchopneumonia |
0.6% |
|
| Rash |
12.2% |
| Urticaria |
12.1% |
| Vomiting |
9.5% |
| Anaphylactic Reaction |
9.4% |
| Tendonitis |
5.1% |
| Hypersensitivity |
5.0% |
| Nausea |
4.7% |
| Tremor |
4.5% |
| Tendon Rupture |
4.3% |
| Pruritus |
4.2% |
| Dizziness |
3.9% |
| Anaphylactic Shock |
3.4% |
| Paraesthesia |
3.2% |
| Pain In Extremity |
2.8% |
| Death |
2.7% |
| Tendon Pain |
2.7% |
| Dyspnoea |
2.6% |
| Syncope |
2.6% |
| Swelling Face |
2.6% |
| Tachycardia |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.9% |
| Product Used For Unknown Indication |
15.9% |
| Pneumonia |
13.2% |
| Sinusitis |
9.8% |
| Bronchitis |
8.1% |
| Chronic Obstructive Pulmonary Disease |
6.4% |
| Hypertension |
5.3% |
| Asthma |
5.1% |
| Infection |
2.5% |
| Pain |
2.4% |
| Upper Respiratory Tract Infection |
1.9% |
| Pyrexia |
1.9% |
| Urinary Tract Infection |
1.9% |
| Cough |
1.5% |
| Hypersensitivity |
1.5% |
| Psoas Abscess |
1.3% |
| Osteoporosis |
1.2% |
| Prophylaxis |
1.2% |
| Respiratory Tract Infection |
1.1% |
| Depression |
1.1% |
|
| Vomiting |
17.7% |
| Urticaria |
8.7% |
| Tremor |
7.0% |
| Tendon Rupture |
6.8% |
| Drug Hypersensitivity |
6.2% |
| Tendonitis |
5.5% |
| Rotator Cuff Syndrome |
5.3% |
| Weight Decreased |
4.9% |
| Rash |
4.7% |
| Pneumonia |
4.3% |
| Pruritus |
4.1% |
| Dyspnoea |
3.2% |
| Pyrexia |
3.2% |
| Paraesthesia |
3.0% |
| Dizziness |
2.8% |
| Tendon Pain |
2.8% |
| Swelling |
2.6% |
| Sinusitis |
2.4% |
| Stevens-johnson Syndrome |
2.4% |
| Syncope |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.8% |
| Drug Use For Unknown Indication |
25.2% |
| Diffuse Large B-cell Lymphoma |
4.5% |
| Hypertension |
4.2% |
| Pain |
3.8% |
| Prophylaxis |
3.8% |
| Multiple Myeloma |
2.7% |
| Pneumonia |
2.6% |
| Asthma |
2.5% |
| Breast Cancer |
2.3% |
| Osteoporosis |
2.0% |
| Depression |
1.9% |
| Nausea |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Anxiety |
1.7% |
| Metastases To Bone |
1.6% |
| Infection |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Constipation |
1.3% |
| Crohn's Disease |
1.3% |
|
| Weight Decreased |
14.4% |
| Vomiting |
12.5% |
| Pneumonia |
11.8% |
| Pulmonary Embolism |
7.7% |
| Weight Increased |
5.2% |
| Wound Infection Staphylococcal |
5.0% |
| Wheezing |
4.5% |
| Urinary Tract Infection |
3.8% |
| White Blood Cell Count Decreased |
3.7% |
| Death |
3.5% |
| Pyrexia |
3.2% |
| Dyspnoea |
3.1% |
| Syncope |
3.0% |
| Respiratory Failure |
2.8% |
| Septic Shock |
2.8% |
| Thrombocytopenia |
2.8% |
| Sinusitis |
2.7% |
| Vision Blurred |
2.6% |
| Pain |
2.5% |
| Wound Dehiscence |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
18.2% |
| Chronic Sinusitis |
10.6% |
| Cystitis |
6.8% |
| Crohn's Disease |
6.1% |
| Diabetes Mellitus |
6.1% |
| Bronchitis |
5.3% |
| Pneumonia |
5.3% |
| Arrhythmia |
4.5% |
| Disseminated Tuberculosis |
4.5% |
| Nephrotic Syndrome |
4.5% |
| Asthma |
3.0% |
| Atrial Fibrillation |
3.0% |
| Combined Immunodeficiency |
3.0% |
| Cough |
3.0% |
| Hypertension |
3.0% |
| Pain |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Hyperlipidaemia |
2.3% |
| Pulmonary Congestion |
2.3% |
| Sinusitis |
2.3% |
|
| Drug Interaction |
25.5% |
| Tendon Rupture |
14.9% |
| International Normalised Ratio Increased |
8.5% |
| Hypoglycaemia |
4.3% |
| Incision Site Abscess |
4.3% |
| Malaise |
4.3% |
| Somnolence |
4.3% |
| Torsade De Pointes |
4.3% |
| Tremor |
4.3% |
| Urticaria |
4.3% |
| Ageusia |
2.1% |
| Aggression |
2.1% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Gastrointestinal Haemorrhage |
2.1% |
| Infection |
2.1% |
| Mastitis |
2.1% |
| Palpitations |
2.1% |
| Panic Attack |
2.1% |
| Post Procedural Infection |
2.1% |
| Prothrombin Time Prolonged |
2.1% |
|
